Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
D000806:Angiotensin-Converting Enzyme Inhibitors; D001665:Binding Sites; D001667:Binding, Competitive; D002216:Captopril / Q000494:pharmacology*; D002384:Catalysis; D008961:Models, Structural; D009842:Oligopeptides / Q000494:pharmacology*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D011392:Proline / Q000031:analogs & derivatives*; D012910:Snake Venoms / Q000378:metabolism; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D013722:Teprotide / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D012910:Snake Venoms; D011392:Proline; D002216:Captopril; D013722:Teprotide; D007703:Peptidyl-Dipeptidase A